Takashi Kawachi

Dr. Takashi Kawachi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2015 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YSYuji Sumii
Yuji Sumii
NKNaoyuki Kotoku
Naoyuki Kotoku
AFAkinori Fukuda
Akinori Fukuda
TKTakashi Kawachi
Takashi Kawachi
Masayoshi AraiMasayoshi Arai
Masayoshi Arai
MKMotomasa Kobayashi
Motomasa Kobayashi
Oral dictyoceratin-C (1) and A (2), hypoxia-selective growth inhibitors, showed potent in vivo antitumor effects in mice subcutaneously inoculated with sarcoma S180 cells. Structurally modified analogs were synthesized to assess the structure–activity relationship of the natural compounds 1 and 2 isolated from a marine sponge. Biological evaluation of these analogs showed that the exo-olefin and hydroxyl and methyl ester moieties were important for the hypoxia-selective growth inhibitory activities of 1 and 2. Thus far, only substitution of the methyl ester with propargyl amide in 1 was found to be effective for the synthesis of probe molecules for target identification.

8 March 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
TKTakashi Kawachi
Takashi Kawachi
STShun Tanaka
Shun Tanaka
AFAkinori Fukuda
Akinori Fukuda
YSYuji Sumii
Yuji Sumii
ASAndi Setiawan
Andi Setiawan
Masayoshi AraiMasayoshi Arai
Masayoshi Arai
Hypoxia-adapted cancer cells in tumors contribute to the pathological progression of cancer. The marine spongean sesquiterpene phenols dictyoceratin-A (1) and -C (2) have been shown to induce hypoxia-selective growth inhibition in cultured cancer cells and exhibit in vivo antitumor effects. These compounds inhibit the accumulation of hypoxia-inducible factor-1α (HIF-1α), which is a drug target in hypoxia-adapted cancer cells, under hypoxic conditions. However, the target molecules of compounds 1 and 2, which are responsible for decreasing HIF-1α expression under hypoxic conditions, remain unclear. In this study, we synthesized probe molecules for compounds 1 and 2 to identify their target molecules and found that both compounds bind to RNA polymerase II-associated protein 3 (RPAP3), which is a component of the R2TP/Prefoldin-like (PEDL) complex. In addition, RPAP3-knockdown cells showed a phenotype similar to that of compound-treated cells.